MobilEye Global Inc vs 22nd Century Group Inc — how do they compare? MobilEye Global Inc trades at $7.1 (market cap $6.00B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: MobilEye Global Inc is far larger — about 9651.4× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 7,007,849). Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and 22nd Century Group Inc for 32 Days on average.
| MBLY | XXII | |
|---|---|---|
Market Cap | $6.00B | $621.67K |
Volume | 7,007,849 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $15.42 | $483.00 |
52-Week Low | $6.56 | $0.80 |
Typical Hold Time | 15 Days | 32 Days |
Enterprise Value | $4.56B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.10, down 0.7% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong revenue growth to $2.0B in 2026 but deep net losses widening to -$4.1B. Analyst consensus leans bullish with 57.7% buy ratings and $10.83 price target, though technical indicators show selling pressure with RSI near oversold levels at 29.04. Recent news highlights ADAS business momentum and autonomous vehicle expansion initiatives.
MBLY presents a high-risk opportunity with significant upside potential if execution improves, but current profitability challenges and bearish technicals warrant caution. The 42% discount to book value and institutional accumulation offer value appeal, though sustained losses and competitive pressures in autonomous driving create substantial execution risk for investors.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →